Tag: HAE
Takeda pledges support to HAE patients through its ‘Sunrise patient support...
The initiative aims to drive HAE awareness through patient education, and timely diagnosis through free of cost diagnostics as the key growth drivers to address priority unmet needs
Takeda launches drug for treating hereditary angioedema patients in India
CINRYZE™ is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE